Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cecilia Oslakovic

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Journal of Clinical Investigation|May 7, 2010
Reevaluation of the role of HDL in the anticoagulant activated protein C system in humansCecilia Oslakovic, Eva Norstrøm, Björn Dahlbäck
Nanomedicine : Nanotechnology, Biology, and Medicine|December 27, 2011
Polystyrene nanoparticles affecting blood coagulationCecilia Oslakovic, Tommy Cedervall, Sara Linse, et al.
Plos One|June 10, 2010
Modeling the time evolution of the nanoparticle-protein corona in a body fluidDaniele Dell'Orco, Martin Lundqvist, Cecilia Oslakovic, et al.
The Journal of Biological Chemistry|January 9, 2009
Anionic phospholipids lose their procoagulant properties when incorporated into high density lipoproteinsCecilia Oslakovic, Michael J Krisinger, Astra Andersson, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|October 8, 2011
Structural changes in apolipoproteins bound to nanoparticlesRisto Cukalevski, Martin Lundqvist, Cecilia Oslakovic, et al.
Plos One|February 6, 2009
Tensin3 is a negative regulator of cell migration and all four Tensin family members are downregulated in human kidney cancerDanuta Martuszewska, Börje Ljungberg, Martin Johansson, et al.
Biochemical and Biophysical Research Communications|August 4, 2010
Tensin2 reduces intracellular phosphatidylinositol 3,4,5-trisphosphate levels at the plasma membraneSassan Hafizi, Anna Gustafsson, Cecilia Oslakovic, et al.
Biochimica Et Biophysica Acta|May 5, 2012
Biocompatibility of mannan nanogel--safe interaction with plasma proteinsSílvia A Ferreira, Cecilia Oslakovic, Risto Cukalevski, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Clinical Investigation|May 7, 2010
Reevaluation of the role of HDL in the anticoagulant activated protein C system in humansCecilia Oslakovic, Eva Norstrøm, Björn Dahlbäck
Nanomedicine : Nanotechnology, Biology, and Medicine|December 27, 2011
Polystyrene nanoparticles affecting blood coagulationCecilia Oslakovic, Tommy Cedervall, Sara Linse, et al.
Plos One|June 10, 2010
Modeling the time evolution of the nanoparticle-protein corona in a body fluidDaniele Dell'Orco, Martin Lundqvist, Cecilia Oslakovic, et al.
The Journal of Biological Chemistry|January 9, 2009
Anionic phospholipids lose their procoagulant properties when incorporated into high density lipoproteinsCecilia Oslakovic, Michael J Krisinger, Astra Andersson, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|October 8, 2011
Structural changes in apolipoproteins bound to nanoparticlesRisto Cukalevski, Martin Lundqvist, Cecilia Oslakovic, et al.
Plos One|February 6, 2009
Tensin3 is a negative regulator of cell migration and all four Tensin family members are downregulated in human kidney cancerDanuta Martuszewska, Börje Ljungberg, Martin Johansson, et al.
Biochemical and Biophysical Research Communications|August 4, 2010
Tensin2 reduces intracellular phosphatidylinositol 3,4,5-trisphosphate levels at the plasma membraneSassan Hafizi, Anna Gustafsson, Cecilia Oslakovic, et al.
Biochimica Et Biophysica Acta|May 5, 2012
Biocompatibility of mannan nanogel--safe interaction with plasma proteinsSílvia A Ferreira, Cecilia Oslakovic, Risto Cukalevski, et al.
Pageof 1